Predicting and monitoring response to head and neck cancer radiotherapy using multimodality imaging and radiobiological digital twin simulations Journal Article


Authors: Aliotta, E.; Jeong, J.; Paudyal, R.; Grkovski, M.; Diplas, B.; Han, J.; Hatzoglou, V.; Aristophanous, M.; Riaz, N.; Schòˆder, H.; Lee, N. Y.; Shukla-Dave, A.; Deasy, J. O.
Article Title: Predicting and monitoring response to head and neck cancer radiotherapy using multimodality imaging and radiobiological digital twin simulations
Abstract: Objective. To predict radiotherapy treatment response for head and neck cancer (HNC) using multimodality imaging and personalized radiobiological modeling. Approach. A mechanistic radiobiological model was combined with multi-modality imaging data from diffusion weighted-magnetic resonance imaging and positron emission tomography scans with [18F]Fluorodeoxyglucose (FDG) and [18F]Fluoromisonidazole (FMISO) tracers to develop personalized treatment response models for human papilloma virus associated HNC patients undergoing chemo-radiotherapy. Models were initialized to incorporate patient-specific imaging and updated to reflect longitudinal measurements of nodal gross tumor volume throughout treatment. Prediction accuracy was assessed based on mean absolute error (MAE) of weekly volume predictions and in predicting locoregional recurrence (LRR) following treatment. Main results. Personalized modeling based on pretreatment imaging significantly improved longitudinal volume prediction accuracy and correlation with measurement compared with a generic population model (MAE = 23.4 +/- 10.0% vs 24.9 +/- 9.0%, p = 0.002 on paired t-test, R = 0.82 vs 0.72). Adding volume measurements from weeks 1 and 2 further improved prediction accuracy for subsequent weeks (MAE = 12.5 +/- 8.1%, 10.7 +/- 9.9%). When incorporating feedback with longitudinal measurements, penalizing large deviations from pretreatment model parameters using a variational regularization method was necessary to maintain model stability. Model-predicted volumes based on baseline + week-1 information significantly improved LRR prediction compared with week-1 volume data alone (area under the curve, AUC = 0.83 vs 0.77, p = 0.03) and was similar to prediction using week-3 volume data (AUC = 0.83 vs 0.85, p = non-significant). Significance. The proposed approach, which integrates clinical imaging and radiobiological principles, could be a basis to guide pretreatment prescription personalization as well as on-treatment adaptations.
Keywords: diffusion; head and neck cancer; quantitative imaging; proliferation; volume; chemoradiation; tumor hypoxia; impact; positron-emission-tomography; radiation-therapy; prognostic value; human-papillomavirus; fdg pet; fmiso pet; diffusion mri; digital twin; radiotherapy response
Journal Title: Physics in Medicine and Biology
Volume: 70
Issue: 11
ISSN: 0031-9155
Publisher: IOP Publishing Ltd  
Date Published: 2025-06-08
Start Page: 115016
Language: English
ACCESSION: WOS:001497277700001
DOI: 10.1088/1361-6560/add9de
PROVIDER: wos
PUBMED: 40378867
PMCID: PMC12169438
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF. Corresponding MSK author is Eric Aliotta -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nadeem Riaz
    417 Riaz
  2. Nancy Y. Lee
    876 Lee
  3. Heiko Schoder
    544 Schoder
  4. Amita Dave
    138 Dave
  5. Joseph Owen Deasy
    524 Deasy
  6. Jeho Jeong
    37 Jeong
  7. James Edward Han
    17 Han
  8. Ramesh Paudyal
    39 Paudyal
  9. Bill Diplas
    17 Diplas
  10. Eric Aliotta
    16 Aliotta